Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
3
60%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)

Trials by Status

completed120%
enrolling_by_invitation120%
active_not_recruiting120%
unknown240%

Recent Activity

1 active trials
Showing 5 of 5
enrolling_by_invitationnot_applicable

Optical Coherence Tomography in Acute Vessel Evaluation

NCT07422688
active_not_recruitingnot_applicable

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

NCT03171311
unknownnot_applicable

Coronary Artery Healing and Bioresorbable Scaffold

NCT03016624
completedphase_4

Mechanism Of Stent Thrombosis (MOST) Study

NCT01410539
unknownphase_3

FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty

NCT01824030

Clinical Trials (5)

Showing 5 of 5 trials
NCT07422688Not Applicable

Optical Coherence Tomography in Acute Vessel Evaluation

Enrolling By Invitation
NCT03171311Not Applicable

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

Active Not Recruiting
NCT03016624Not Applicable

Coronary Artery Healing and Bioresorbable Scaffold

Unknown
NCT01410539Phase 4

Mechanism Of Stent Thrombosis (MOST) Study

Completed
NCT01824030Phase 3

FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty

Unknown

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5